Menu
Recruiting NCT07385170

Perioperative Continuous Glucose Monitoring Accuracy in Cardiac Surgery

Observational Cardiac Surgery

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Dexcom G7.
Who it may be relevant to
Registry conditions: Cardiac Surgery. Basic parameters: from 19 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
South Korea
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Evaluation of Perioperative Continuous Glucose Monitoring Accuracy in Patients Undergoing Cardiac Surgery

Overview

The goal of this clinical trial is to evaluate accuracy of continuous glucose monitoring device called 'Dexcom G7' in patients undergoing cardiac surgery.

Interventions

  • Device Dexcom G7
    Continuous glucose monitoring device (Dexcom G7) will be applied to patients undergoing cardiac surgery intraoperatively and postoperatively (maximum 10 days)

Primary outcome measures

  • MARD [Time frame: From the beginning of operation to the end of postoperative ICU stay (maximum 10 days)]
Secondary outcome measures (3)
  • Bland-Altman analysis [Time frame: From the beginning of operation to the end of postoperative ICU stay (maximum 10 days)]
  • ISO criteria [Time frame: From the beginning of operation to the end of postoperative ICU stay (maximum 10 days)]
  • DTS error grid [Time frame: From the beginning of operation to the end of postoperative ICU stay (maximum 10 days)]

Eligibility criteria

Inclusion criteria

  • Patients aged 19 years or older scheduled for cardiac surgery

Exclusion criteria

  • Skin disease at the sensor application site (proximal arm)

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

South Korea · 1 center
  • Seoul National University Hospital — Seoul

Identifiers

NCT: NCT07385170 · CGM-CS

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗